Position in XENE
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$28,228,219
New position
Shares Held
485,438
first reported quarter
Ownership
0.502%
of shares outstanding
% of Portfolio
2.28%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Position in Biotechnology
Healthcare · as of Mar 31, 2026NOVO HOLDINGS A/S holds $857,300,211 across 16 Biotechnology names. XENE ranks #14 (3.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | EWTX |
Edgewise Therapeutics, Inc.
|
5,350,000 | $168,525,000 | |
| 2 | MIRM |
Mirum Pharmaceuticals, Inc.
|
1,325,000 | $122,403,500 | |
| 3 | MPLT |
MapLight Therapeutics, Inc.
|
3,686,622 | $74,949,025 | |
| 4 | CRNX |
Crinetics Pharmaceuticals, Inc.
|
1,550,000 | $56,296,000 | |
| 5 | ELVN |
Enliven Therapeutics, Inc.
|
1,280,000 | $50,176,000 | |
| 6 | PCVX |
Vaxcyte, Inc.
|
860,000 | $49,974,600 | |
| 7 | PHVS |
Pharvaris N.V.
|
1,750,000 | $49,437,500 | |
| 8 | AVBP |
ArriVent BioPharma, Inc.
|
1,942,142 | $44,805,215 |
All Filings in XENE
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $28,228,219 | 485,438 | Shares | Sole | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||